{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:05:33Z","timestamp":1793171133482,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00415-022-11417-z","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T19:18:49Z","timestamp":1667589529000},"page":"1776-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG\/anti-Ca autoantibody-associated autoimmune encephalitis"],"prefix":"10.1007","volume":"270","author":[{"given":"Sven","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"11417_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-2094-7-21","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B (2010) A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflamm 7:21","journal-title":"J Neuroinflamm"},{"key":"11417_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u201cMedusa head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflamm 12:168","journal-title":"J Neuroinflamm"},{"key":"11417_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-015-0357-x","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u201cMedusa head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC. J Neuroinflamm 12:167","journal-title":"J Neuroinflamm"},{"key":"11417_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B (2015) \u201cMedusa-head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII. J Neuroinflamm 12:166","journal-title":"J Neuroinflamm"},{"key":"11417_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-2094-10-7","volume":"10","author":"S Jarius","year":"2013","unstructured":"Jarius S, Martinez-Garcia P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stocker W, Wildemann B, Wandinger KP (2013) Two new cases of anti-Ca (anti-ARHGAP26\/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflamm 10:7","journal-title":"J Neuroinflamm"},{"key":"11417_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2013.10.010","volume":"267","author":"S Doss","year":"2014","unstructured":"Doss S, N\u00fcmann A, Ziegler A, Siebert E, Borowski K, St\u00f6cker W, Pr\u00fcss H, Wildemann B, Endres M, Jarius S (2014) Anti-Ca\/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline. J Neuroimmunol 267:102\u2013104","journal-title":"J Neuroimmunol"},{"key":"11417_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2017.05.011","volume":"309","author":"U Wallwitz","year":"2017","unstructured":"Wallwitz U, Brock S, Schunck A, Wildemann B, Jarius S, Hoffmann F (2017) From dizziness to severe ataxia and dysarthria: new cases of anti-Ca\/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum. J Neuroimmunol 309:77\u201381","journal-title":"J Neuroimmunol"},{"key":"11417_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jneuroim.2015.07.009","volume":"286","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B, Stocker W, Moser A, Wandinger KP (2015) Psychotic syndrome associated with anti-Ca\/ARHGAP26 and voltage-gated potassium channel antibodies. J Neuroimmunol 286:79\u201382","journal-title":"J Neuroimmunol"},{"key":"11417_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fneur.2018.00656","volume":"9","author":"F Bartels","year":"2018","unstructured":"Bartels F, Pruss H, Finke C (2018) Anti-ARHGAP26 autoantibodies are associated with isolated cognitive impairment. Front Neurol 9:656","journal-title":"Front Neurol"},{"key":"11417_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mdc3.13036","volume":"7","author":"SJ Pittock","year":"2020","unstructured":"Pittock SJ, Alfugham N, O\u2019Connor K, Hinson S, Kunchok A, Lennon VA, Komorowski L, Probst C, McKeon A (2020) GTPase regulator associated with focal adhesion kinase 1 (GRAF1) immunoglobulin-associated ataxia and neuropathy. Mov Disord Clin Pract 7:904\u2013909","journal-title":"Mov Disord Clin Pract"},{"key":"11417_CR11","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Muniz-Castrillo S, Antoine JG, Desestret V, Dubey D, Giometto B, Irani SR, Joubert B, Leypoldt F et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8:e1014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11417_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0006-291X(02)00514-4","volume":"294","author":"DS Basseres","year":"2002","unstructured":"Basseres DS, Tizzei EV, Duarte AA, Costa FF, Saad ST (2002) ARHGAP10, a novel human gene coding for a potentially cytoskeletal Rho-GTPase activating protein. Biochem Biophys Res Commun 294:579\u2013585","journal-title":"Biochem Biophys Res Commun"},{"key":"11417_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S et al (2010) Towards a knowledge-based human protein atlas. Nat Biotechnol 28:1248\u20131250","journal-title":"Nat Biotechnol"},{"key":"11417_CR14","first-page":"4602","volume":"127","author":"S Lucken-Ardjomande Hasler","year":"2014","unstructured":"Lucken-Ardjomande Hasler S, Vallis Y, Jolin HE, McKenzie AN, McMahon HT (2014) GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions. J Cell Sci 127:4602\u20134619","journal-title":"J Cell Sci"},{"key":"11417_CR15","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1007\/s00415-022-11178-9","volume":"269","author":"S Jarius","year":"2022","unstructured":"Jarius S, Komorowski L, Regula JU, Haas J, Brakopp S, Wildemann B (2022) Rho GTPase-activating protein 10 (ARHGAP10\/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis. J Neurol 269:5420\u20135430","journal-title":"J Neurol"},{"key":"11417_CR16","doi-asserted-by":"publisher","first-page":"36885","DOI":"10.1074\/jbc.M004069200","volume":"275","author":"A Harada","year":"2000","unstructured":"Harada A, Furuta B, Takeuchi K, Itakura M, Takahashi M, Umeda M (2000) Nadrin, a novel neuron-specific GTPase-activating protein involved in regulated exocytosis. J Biol Chem 275:36885\u201336891","journal-title":"J Biol Chem"},{"key":"11417_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1046\/j.1471-4159.2002.01021.x","volume":"82","author":"B Furuta","year":"2002","unstructured":"Furuta B, Harada A, Kobayashi Y, Takeuchi K, Kobayashi T, Umeda M (2002) Identification and functional characterization of nadrin variants, a novel family of GTPase activating protein for rho GTPases. J Neurochem 82:1018\u20131028","journal-title":"J Neurochem"},{"key":"11417_CR18","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"C UniProt","year":"2019","unstructured":"UniProt C (2019) UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res 47:D506\u2013D515","journal-title":"Nucleic Acids Res"},{"key":"11417_CR19","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhlen","year":"2005","unstructured":"Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C et al (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4:1920\u20131932","journal-title":"Mol Cell Proteomics"},{"key":"11417_CR20","volume-title":"Paraneoplastic syndromes","author":"RB Darnell","year":"2011","unstructured":"Darnell RB, Posner JB (2011) Paraneoplastic syndromes. Oxford University Press, Oxford, New York"},{"key":"11417_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.2007.118588","volume":"79","author":"LA Hoffmann","year":"2008","unstructured":"Hoffmann LA, Jarius S, Pellkofer HL, Schueller M, Krumbholz M, Koenig F, Johannis W, la Fougere C, Newman T, Vincent A, Voltz R (2008) Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 79:767\u2013773","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11417_CR22","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1073\/pnas.0510655103","volume":"103","author":"P Buttery","year":"2006","unstructured":"Buttery P, Beg AA, Chih B, Broder A, Mason CA, Scheiffele P (2006) The diacylglycerol-binding protein alpha1-chimaerin regulates dendritic morphology. Proc Natl Acad Sci U S A 103:1924\u20131929","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11417_CR23","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347:1260419","journal-title":"Science"},{"key":"11417_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pro.3290","volume":"27","author":"F Sievers","year":"2018","unstructured":"Sievers F, Higgins DG (2018) Clustal Omega for making accurate alignments of many protein sequences. Protein Sci 27:135\u2013145","journal-title":"Protein Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11417-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:04:02Z","timestamp":1677503042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["11417"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11417-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.J., J.H. and B.W. report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the institutional review board of the University of Heidelberg and the patient gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}